Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

NCT03611231 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Experimental Tumor

Interventions

DRUG: Chidamide

Sponsor

Peking University

Collaborators

[object Object]
[object Object]